ASH Ashland Global Holdings Inc.

Ashland sets date for fourth-quarter fiscal 2024 earnings release and conference call webcast

Ashland sets date for fourth-quarter fiscal 2024 earnings release and conference call webcast

WILMINGTON, Del., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its fourth-quarter fiscal 2024 earnings release at approximately 5 p.m. ET on Wednesday, November 6, 2024. The company’s live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 9 a.m. ET on Thursday, November 7. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at .

Among those participating in the webcast presentation will be:

  • Guillermo Novo, chair, and chief executive officer
  • Kevin Willis, senior vice president and chief financial officer
  • Dago Caceres, senior vice president, general manager, specialty additives
  • Alessandra Faccin, senior vice president, general manager, life sciences and intermediates
  • Jim Minicucci, senior vice president, general manager, personal care
  • William Whitaker, vice president finance and director, investor relations

To access the call by phone, please go to and you will be provided with dial in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time.

The webcast and supporting materials will be accessible through the Investor Relations section of Ashland's website at . Following the live event, an archived version of the webcast and supporting materials will be available on the Ashland website for 12 months.

About Ashland 

Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceutical. Approximately 3,200 passionate, tenacious solvers – from renowned scientists and research chemists to talented engineers and plant operators – thrive on developing practical, innovative and elegant solutions to complex problems for customers in more than 100 countries. Visit  and  to learn more.

™ Trademark, Ashland, or its subsidiaries, registered in various countries.

FOR FURTHER INFORMATION:

Investor Relations:Media Relations:
William WhitakerCarolmarie C. Brown
+1 (614) 790-2095+1 (302) 995-3158

Attachment



EN
28/10/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ashland Global Holdings Inc.

 PRESS RELEASE

Ashland to host live 2024 strategy update event for analysts and inves...

Ashland to host live 2024 strategy update event for analysts and investors WILMINGTON, Del., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host a strategy update event for analysts and investors on Tuesday, December 10, 2024, in New York City. The company will provide an in-depth review of Ashland’s strategic priorities, key initiatives and financial objectives while emphasizing a proactive approach to market uncertainty in fiscal year 2025. The event will include presentations and prepared remarks from members of Ashland’s executive team, as well as breakout sessions f...

 PRESS RELEASE

Ashland reports financial results for fourth-quarter fiscal 20241, iss...

Ashland reports financial results for fourth-quarter fiscal 20241, issues outlook for full-year fiscal 2025, provides portfolio optimization update and announces strategy update event Financial results for fourth-quarter fiscal 20241 Sales of $522 million, up one percent from the prior-year quarterSold nutraceuticals business to Turnspire Capital Partners LLCPreviously announced carboxymethylcellulose (CMC), methylcellulose (MC) and nutraceuticals portfolio optimization initiatives reduced overall sales by approximately $24 million or five percent versus the prior-year quarterIncome from c...

 PRESS RELEASE

Ashland sets date for fourth-quarter fiscal 2024 earnings release and ...

Ashland sets date for fourth-quarter fiscal 2024 earnings release and conference call webcast WILMINGTON, Del., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its fourth-quarter fiscal 2024 earnings release at approximately 5 p.m. ET on Wednesday, November 6, 2024. The company’s live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 9 a.m. ET on Thursday, November 7. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website...

 PRESS RELEASE

Ashland accelerates application of super wetting technology, commercia...

Ashland accelerates application of super wetting technology, commercializes superior wetting agent for corn, soy, wheat, watermelon, other produce and florals Technology successfully validated by field trials and successful customer pilots; commercial samples and material now available Wilmington, Del., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Ashland has accelerated the application of the company’s new super wetting technology platform announced last September. The company has commercialized for corn, soy and wheat as well as watermelon, florals and other produce including bananas, lettuce...

 PRESS RELEASE

Ashland completes sale of nutraceuticals business

Ashland completes sale of nutraceuticals business WILMINGTON, Del., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced it has completed the sale of its nutraceuticals business to an affiliate of Turnspire Capital Partners LLC (“Turnspire”) effective August 30, 2024. The sale includes custom formulation and contract manufacturing capabilities for the nutrition market from the production facilities in New Jersey and Utah in the United States, and Tamaulipas, Mexico. Financial terms of the transaction were not disclosed. “The nutraceuticals business has a strong po...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch